The Clinicopathological Parameters for Making the Differential Diagnosis of Neonatal Cholestasis
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background : The diseases that cause neonatal cholestasis display several overlapping clinical feature. Making the differential diagnosis using liver biopsy specimens from infants with neonatal cholestasis is important for delivering the proper treatment. Methods : We assessed the clinical manifestations, laboratory data, and histopathologic features of the pretreatment liver biopsy specimens from patients suffering with biliary atresia (n=66), intrahepatic bile duct paucity (n=15), and neonatal hepatitis (n=21). Results : The gender distribution was nearly equal for the patients with biliary atresia and intrahepatic bile duct paucity, whereas males predominated for the cases of neonatal hepatitis. Only the gamma-glutamyl transferase level differed significantly amongst the groups. The diagnostic features for making the differential diagnosis of bile duct lesions included marked bile ductular proliferation, severe fibrosis, and bile duct loss. The difference of the average percentage of portal tracts with bile duct loss was statistically significant between the patients with intrahepatic bile duct paucity (73.9%) and those patients with neonatal hepatitis (39.1%) (p<0.001). Conclusions : Bile ductular proliferation, bile duct loss, and advanced fibrosis are useful for the differential diagnosis of neonatal cholestasis. Moreover, stricter diagnostic criteria for bile duct loss (more than 2/3 of bile ducts) should be applied for the definitive diagnosis of intrahepatic bile duct paucity, because bile duct loss also frequently occurs in infants suffering with neonatal hepatitis.
Abstract
Background : The diseases that cause neonatal cholestasis display several overlapping clinical feature. Making the differential diagnosis using liver biopsy specimens from infants with neonatal cholestasis is important for delivering the proper treatment. Methods : We assessed the clinical manifestations, laboratory data, and histopathologic features of the pretreatment liver biopsy specimens from patients suffering with biliary atresia (n=66), intrahepatic bile duct paucity (n=15), and neonatal hepatitis (n=21). Results : The gender distribution was nearly equal for the patients with biliary atresia and intrahepatic bile duct paucity, whereas males predominated for the cases of neonatal hepatitis. Only the gamma-glutamyl transferase level differed significantly amongst the groups. The diagnostic features for making the differential diagnosis of bile duct lesions included marked bile ductular proliferation, severe fibrosis, and bile duct loss. The difference of the average percentage of portal tracts with bile duct loss was statistically significant between the patients with intrahepatic bile duct paucity (73.9%) and those patients with neonatal hepatitis (39.1%) (p<0.001). Conclusions : Bile ductular proliferation, bile duct loss, and advanced fibrosis are useful for the differential diagnosis of neonatal cholestasis. Moreover, stricter diagnostic criteria for bile duct loss (more than 2/3 of bile ducts) should be applied for the definitive diagnosis of intrahepatic bile duct paucity, because bile duct loss also frequently occurs in infants suffering with neonatal hepatitis.
참고문헌 (19)
- McKiernan PJ, "Neonatal cholestasis", Semin Neonatol, 7, pp.153~165 (2002)
- Crawford JM, "Basic mechanisms in hepatopathology. in: MacSween’s pathology of the liver", pp.85~88 (2007), Elsevier
- Venigalla S, "Neonatal cholestasis", Semin Perinatol, 28, pp.348~355 (2004)
- Portmann BC, "Developmental abnormalities and liver disease in childhood. in: MacSween’s pathology of the liver", pp.153~168 (2007), Elsevier
- Karrer FM, "Long-term results with the Kasai operation for biliary atresia", Arch Surg, 131, pp.493~496 (1996)
- Oh M, "The Kasai procedure in the treatment of biliary atresia", J Pediatr Surg, 30, pp.1077~1080 (1995)
- Sung SH, "Neonatal hepatitis and extrahepatic biliary atresia: a comparison by scoring the histological parameters", Korean J Pathol, 25, pp.445~456 (1991)
- Zerbini MC, "Liver biopsy in neonatal cholestasis: a review on statistical grounds", Mod Pathol, 10, pp.793~799 (1997)
- Kim KM, "Evaluation of the underlying etiology and longterm prognostic factors in neonatal cholestasis", Korean J Pediatr Gastroenterol Nutr, 2, pp.46~58 (1999)
- Crawford AR, "The normal adult human liver biopsy: a quantitative reference standard", Hepatology, 28, pp.323~331 (1998)
- Scheuer PJ, "Liver biopsy interpretation", pp.23~ (2006), Elsevier saunders
- Liu CS, "Value of gamma-glutamyl transpeptidase for early diagnosis of biliary atresia", Zhonghua Yi Xue Za Zhi, 61, pp.716~720 (1998)
- Johnson K, "Evaluation of mebrofenin hepatoscintigraphy in neonatal-onset jaundice", Pediatr Radiol, 28, pp.937~941 (1998)
- Suchy FJ, "Approach to the infant with cholestasis. in: Liver disease in children", pp.187~194 (2001), Lippincott Williams & Wilkins
- Kim WS, "Comparison of Tc-99m DISIDA hepatobiliary scintigraphy and percutaneous needle biopsy in the diagnosis of biliary atresia from Intrahepatic cholestasis", J Korean Assoc Pediatr Surg, 3, pp.6~14 (1997)
- Gilmour SM, "Outcome of hepatobiliary scanning in neonatal hepatitis syndrome", J Nucl Med, 38, pp.1279~1282 (1997)
- Lee BS, "Diagnostic utility of Tc-99m DISIDA hepatobiliary scintigraphy in the diagnosis of biliary atresia", Korean J Pediatr Gastroenterol Nutr, 3, pp.63~67 (2000)
- Balistreri WF, "Neonatal cholestasis", J Pediatr, 106, pp.171~184 (1985)
- 고재성, "신생아 담즙정체의 원인질환", Korean Journal of Pediatrics, 50(9), pp.835~840 (2007), 대한소아과학회